Omeros | OMER - Ebitda





Ebitda 변화 날짜
Adma Biologics USD 73.59M 14.85M 2025-12
Alnylam Pharmaceuticals USD 145.22M 236.56M 2025-12
BioMarin Pharmaceutical USD 146.05M 170.22M 2026-03
Cytokinetics USD -149.83M 127.34M 2025-12
Gilead Sciences USD 3.02B 1.01B 2025-12
Heron Therapeutics USD -3.88M 5.63M 2024-09
Immunic USD -22.78M 753K 2024-06
Insmed USD -314.19M 31.48M 2025-12
Knight Therapeutics CAD 24.45M 3.46M 2025-12
MacroGenics USD 21.95M 55.39M 2025-09
Omeros USD -47.96M 7.39M 2023-09
Pacira USD 40.24M 1.53M 2026-03
Pfizer USD 756M 5.32B 2025-12
Sarepta Therapeutics USD -168.03M 294.45M 2025-09
United Therapeutics USD 379.5M 83.4M 2025-12
Vertex Pharmaceuticals USD 1.39B 48.8M 2025-12
Xoma USD 2.52M 7.98M 2024-06